Table 9: Commercially available POC devices for cancer detection.

POC NAME MEASURED PARAMETERS TEST TIME IMPRECISION ACCURACY
HemoCue® WBC DIFF (HemoCue®, Sweden) [327] WBC 5 minutes CV = 1 - 13.7% r > 0.95
PSAwatch (Mediwatch Plc, Rugby, UK) [328] PSA 10 minutes N/A r = 0.88
EZ DETECT™ (Biomerica, Inc., Irvine, USA) [329] FOB 2 minutes N/A r = 0.70
NMP22 BladderChek Test (Matritech, MA, USA) [330, 331] urine NMP22 30 minutes N/A r = 0.82
UBC® rapid test (Concile GmbH, Freiburg/Breisgau, Germany) [332, 333] CYFRA 8 and 18 10 minutes N/A r = 0.77
BTA® stat (Polymedco, Inc., Cortlandt Manor, NY) [334, 335] CFHRP 5 minutes N/A r = 0.85
CancerCheck® PSA (concile GmbH, Freiburg, Germany) [336] PSA 20 minutes N/A r = 0.74
Prevent ID CC (Immundiagnostik AG, Bensheim, Germany) [337, 338] FOB 10 minutes N/A N/A
Quantum Blue® (BÜHLMANN Laboratories AG, Schönenbuch,
Switzerland) [339, 340]		 calprotectin 12 minutes CV = 4.6 - 5.9% r = 0.73
M2-PK™ stool test (ScheBo Biotech AG, Giessen, Germany) [341-343] Pyruvate kinase isoenzyme 120 minutes CV = 4.5 - 6.1% r = 0.96
FastPack® IP System (Sekisui Diagnostics, LLC, Lexington, USA) [114] PSA 12 minutes CV = 9.4 - 13.1% r = 0.97
free PSA CV = 11.6 - 13.9 r = 0.97

(WBC = White Blood Cells, PSA = Prostate-Specific Antigen; FOB = Fecal occult blood; NMP22 = nuclear matrix protein 22; CYFRA = cytokeratin fragment; CFHRP = complement factor H–related protein).